Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
NCT00120900
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1340
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoarthritis, Knee
Interventions
DRUG:
GW406381
Sponsor
GlaxoSmithKline